Well, I dont get it. When the cycle in top of its pick, none of big companies want to do M&A with huge premium plus hyped share price. They need to pay way more premium than bottom cycle. Investing on R&D more happen in top of the cycle. In bottom cycle, most companies try to reduce its expence and production and big companies are looking for buying potential company with lowest budget. Thats normally M&A happen. Some M&A happen in hype due to expanding supplyline or too much demand on certain companies. Offtakes more likely happen in top of the cycle I guess
- Forums
- ASX - By Stock
- WR1
- WR1 General Discussion
WR1 General Discussion, page-33157
Featured News
Add WR1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
52.5¢ |
Change
0.015(2.94%) |
Mkt cap ! $116.2M |
Open | High | Low | Value | Volume |
53.0¢ | 54.0¢ | 52.0¢ | $317.7K | 600.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14196 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.5¢ | 26539 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14196 | 0.520 |
2 | 10591 | 0.515 |
7 | 140445 | 0.510 |
2 | 8321 | 0.505 |
4 | 209000 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.525 | 26539 | 1 |
0.530 | 11514 | 1 |
0.535 | 18101 | 3 |
0.540 | 25000 | 1 |
0.545 | 55000 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
WR1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online